scispace - formally typeset
P

Peter Pickkers

Researcher at Radboud University Nijmegen

Publications -  551
Citations -  24686

Peter Pickkers is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Sepsis & Intensive care. The author has an hindex of 70, co-authored 501 publications receiving 17971 citations. Previous affiliations of Peter Pickkers include Radboud University Nijmegen Medical Centre & Waikato Hospital.

Papers
More filters
Journal ArticleDOI

Crew Resource Management in the trauma room: a prospective 3-year cohort study.

TL;DR: Following CRM implementation in the ED, safety climate improved significantly in three out of six Safety Attitudes Questionnaire domains, both at the end of the implementation and clinical effect years: teamwork climate, safetyClimate, and stress recognition.
Journal ArticleDOI

The Effects of Cold Exposure Training and a Breathing Exercise on the Inflammatory Response in Humans: A Pilot Study

TL;DR: The combination of cold exposure training and a breathing exercise most potently attenuates the in vivo inflammatory response in healthy young males and demonstrates that the immunomodulatory effects of the intervention can be reproduced in a standardized manner, thereby paving the way for clinical trials.
Journal ArticleDOI

Long-Term Effects of Experimental Human Endotoxemia on Immune Cell Function: Similarities and Differences With Sepsis.

TL;DR: Despite considerable differences, experimental endotoxemia captures several long-term aspects of sepsis immunology, specifically the behavior of CD8+ T cells, which may eventually aid the development of new therapies for septic shock patients.
Journal Article

IFN-gamma is not induced through increased plasma concentrations of interleukin-12/interleukin-18 during human endotoxemia.

TL;DR: Results indicate that pathways other than the IL-12/IL-18 axis may induce IFN-gamma production in human endotoxemia.
Journal ArticleDOI

What's new in immunostimulating strategies in the ICU.

TL;DR: A multilayered omics-based immunoprofiling will provide detailed information to facilitate novel precision immunotherapies in sepsis, and a combination of prognostic and predictive strategies based on serum protein and messenger RNA biomarkers could identify a subgroup of children with septic shock that may be more likely to benefit from corticosteroids.